Literature DB >> 19967688

Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.

Zhiliang Cheng1, Daniel L J Thorek, Andrew Tsourkas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19967688      PMCID： PMC2862691          DOI： 10.1002/anie.200905133

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  21 in total

Review 1.  Safety of magnetic resonance imaging contrast agents.

Authors:  F G Shellock; E Kanal
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

2.  Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI.

Authors:  Anne M Morawski; Patrick M Winter; Kathryn C Crowder; Shelton D Caruthers; Ralph W Fuhrhop; Michael J Scott; J David Robertson; Dana R Abendschein; Gregory M Lanza; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

3.  Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.

Authors:  E C Unger; P MacDougall; P Cullis; C Tilcock
Journal:  Magn Reson Imaging       Date:  1989 Jul-Aug       Impact factor: 2.546

4.  Hybrid silica nanoparticles for multimodal imaging.

Authors:  William J Rieter; Jason S Kim; Kathryn M L Taylor; Hongyu An; Weili Lin; Teresa Tarrant; Wenbin Lin
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging.

Authors:  Sjoerd Hak; Honorius M H F Sanders; Prashant Agrawal; Sander Langereis; Holger Grüll; Henk M Keizer; Francesca Arena; Enzo Terreno; Gustav J Strijkers; Klaas Nicolay
Journal:  Eur J Pharm Biopharm       Date:  2008-10-10       Impact factor: 5.571

6.  Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates.

Authors:  M G Duarte; M H Gil; J A Peters; J M Colet; L V Elst; R N Muller; C F Geraldes
Journal:  Bioconjug Chem       Date:  2001 Mar-Apr       Impact factor: 4.774

7.  Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.

Authors:  Sander Langereis; Quido G de Lussanet; Marcel H P van Genderen; E W Meijer; Regina G H Beets-Tan; Arjan W Griffioen; Jos M A van Engelshoven; Walter H Backes
Journal:  NMR Biomed       Date:  2006-02       Impact factor: 4.044

8.  PAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: the interplay of global motion, internal rotation, and fast water exchange.

Authors:  Jakub Rudovský; Mauro Botta; Petr Hermann; Kenneth I Hardcastle; Ivan Lukes; Silvio Aime
Journal:  Bioconjug Chem       Date:  2006 Jul-Aug       Impact factor: 4.774

9.  Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.

Authors:  Peter Caravan; Christian T Farrar; Luca Frullano; Ritika Uppal
Journal:  Contrast Media Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 3.161

10.  Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications.

Authors:  Enzo Terreno; Daniela Delli Castelli; Claudia Cabella; Walter Dastrù; Alberto Sanino; Joseph Stancanello; Lorenzo Tei; Silvio Aime
Journal:  Chem Biodivers       Date:  2008-10       Impact factor: 2.745
View more
  35 in total

1.  Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 2.  Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Authors:  Liangqian Tong; Ming Zhao; Shu Zhu; Jing Chen
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

3.  MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.

Authors:  Mingqian Tan; Susan M Burden-Gulley; Wen Li; Xueming Wu; Daniel Lindner; Susann M Brady-Kalnay; Vikas Gulani; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

4.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

5.  Metal-containing and related polymers for biomedical applications.

Authors:  Yi Yan; Jiuyang Zhang; Lixia Ren; Chuanbing Tang
Journal:  Chem Soc Rev       Date:  2016-02-24       Impact factor: 54.564

Review 6.  Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.

Authors:  Ching-Hui Huang; Andrew Tsourkas
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

7.  A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.

Authors:  Xiangdong Xue; Ruonan Bo; Haijing Qu; Bei Jia; Wenwu Xiao; Ye Yuan; Natalia Vapniarsky; Aaron Lindstrom; Hao Wu; Dalin Zhang; Longmeng Li; Marina Ricci; Zhao Ma; Zheng Zhu; Tzu-Yin Lin; Angelique Y Louie; Yuanpei Li
Journal:  Biomaterials       Date:  2020-07-15       Impact factor: 12.479

8.  Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

Authors:  Ching-Hui Huang; Kido Nwe; Ajlan Al Zaki; Martin W Brechbiel; Andrew Tsourkas
Journal:  ACS Nano       Date:  2012-10-29       Impact factor: 15.881

9.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.

Authors:  Michael A Bruckman; Stephen Hern; Kai Jiang; Chris A Flask; Xin Yu; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2013-03-14       Impact factor: 6.331

10.  Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

Authors:  Ian R Corbin; Kenneth K Ng; Lili Ding; Andrea Jurisicova; Gang Zheng
Journal:  Nanomedicine (Lond)       Date:  2012-10-15       Impact factor: 5.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.